Posts

Image of the "Best Rheumatoid Arthritis Apps 2019" from Healthline Media
Image of the "Best Rheumatoid Arthritis Apps 2019" from Healthline Media

In a late May article by Healthline, cliexa-RA was named one of the “Best Rheumatoid Arthritis Apps of 2019.” For the second straight year, cliexa-RA has been nominated for this selection, receiving a perfect five stars on the iOS App Store and the highest average score among all apps named. With the extensive features, assessments, accuracy, and patient-physician efficiency included with the application, it is one of the most thorough rheumatoid arthritis apps on the market.

cliexa-RA is a specially designed app for tracking patient progress, medication adherence, and complications from the patient’s smartphone. It includes several medically validated and custom assessments for keeping tabs on patients and providing physicians with accurate and up-to-date information. The app can also use a patient’s medical history and statistical data to more clearly assess patients\’ rheumatoid arthritis progress and therefore help physicians accurately provide treatment plans. The outpatient data helps create efficiency of communication between patient and physician, cutting down on time spent at the clinic and providing more accurate care solutions.

cliexa’s platform implements effective Remote Patient Monitoring to optimize clinical workflow, medical billing compliance, and reimbursements. Accurate outpatient data is essential to the cliexa platform, with cliexa-RA being recognized for its capability to utilize Remote Patient Monitoring effectively.

Read More: The Best Rheumatoid Arthritis Apps of 2019

Previous: The Best Rheumatoid Arthritis Apps of 2018

Mobile Health Applications - Value Based Care

In today’s healthcare system, there is a focus on creating a value-based care system to foster a standard of effectiveness, and efficiency when it comes to patient health outcomes, and reduced costs. Through this model, healthcare providers are incentivized to deliver high quality care and this value is derived from measuring health outcomes over time. There is significant pressure that many providers face to be able to quantify their patient’s health outcomes in order to show they are in fact delivering “value-based care.” A value-based model creates a need for a fruitful cross-communication system that extends to patients, providers, payers, and all involved in the healthcare system in order to quantify and qualify health measures.

In a effort to utilize patient-reported health status to improve care, cliexa is collaborating with the American College of Cardiology to develop technical modules targeting cardiology-specific diseases using remote patient monitoring. The first module, cliexa-PULSE, has been developed is for Atrial Fibrillation and includes patient-reported symptom tracking, medication reconciliation functions, connections to wearable data and claims data connection. This information will fulfill reporting needs for patients through visual tracking graphics in the application and to physicians in a summarized, customized manner. Moving forward we are looking to commercialize this product through the ACC’s 2,500 members and beyond.

Improved communication and reduced costs can be achieved by improving patient engagement, streamlining clinical workflow, and implementing a customizable technology that will automate clinical processes, analyze and simplify patient data, which can lead to improved care and health outcomes. By the incorporation of patients’ health status and value via patient-reported outcomes (PROs), providers can monitor the quality of health care delivery.

PROs can be used as absolute terms, or as a change from a previous result as well as a measurement in clinical trials. Physicians can better determine baseline status, clinical trial endpoints, monitor therapy effectiveness, assess change in stats and prognosis predictor, while the patient experiences positive impacts on daily activities, emotional wellbeing, psychological health, and social function. In addition, PROs can aid clinics to improve patient outcomes, quality of life and satisfaction by using the PROs to better inform their care. PROs prioritize the important details in a clinical encounter and aid a better understanding of the motivation behind patient behavioral change. With this information, the clinic can analyze the evidence, design clinical trials and change their practice and policy. In addition, PROs can aid clinics to improve patient outcomes, quality of life and satisfaction by using the data to better inform their care. PROs prioritize the important details in a clinical encounter and aid a better understanding of the motivation behind patient behavioral change. With this information, the clinic can analyze the evidence, design clinical trials and change their practice and policy.

Patient-centered data collection outside of a traditional clinical is the next frontier of modern healthcare. By digitizing and automating PROs, both patients and physicians benefit financially and through effective time management. PROs tackle the challenge of long surveys, care integration, multimorbid patients, and improving the relationship between patient and provider. Clinicians need instruments (surveys) to capture patient-reported measures of symptom status, functional status and health-related quality of life. PROs help quantify the disease from patients’ perspectives, makes disease- specific measures more sensitive and relevant, help meet all the requirements of performance measures and can improve the process of delivering clinical care while bringing the patients’ voices into care. Physicians have found that PROs, in the right setting with the right workflow, are a helpful mechanism for shared decision making and help tackle the treatment goals of patient survival, free of hospitalization, and increased quality of life.

Read more from ACC: //www.acc.org/latest-in-cardiology/articles/2019/04/14/12/42/innovation-at-acc-collaboration-using-patient-reported-health-status-to-improve-care

The Silicon Review's 30 Best Leaders to Watch in 2019

cliexa’s Founder and CEO, Mehmet Kazgan, is rated as one of the “30 Best Leaders to Watch in 2019” Mehmet was featured in an article highlighting his success as an entrepreneur, and business owner. Mehmet founded cliexa in late 2015 and has been working diligently to grow the company. Mehmet sat down with the Silicon Review team to discuss his experience as a leader in business, and healthcare technology.

Here is a snippet from the article:

“What is your greatest fear, and how do you manage fear?”

“My greatest fear is to over-promise and under-deliver, in any form, within a business or non-business related context. I manage fear by acknowledging it and facing it when the time comes.”

“What were the biggest initial hurdles to building your business and how did you overcome them?”

“Convincing others about my entrepreneurial approach and vision was one of the biggest hurdles. Validating the concept and demonstrating the outcomes was one of the ways I worked to overcome them.”

To read the full article, click HERE.

AHRQ Phase 2 Winners' Spotlight

“cliexa’s vision is to be the state-of-the-art patient-reported outcomes and remote patient monitoring platform for comorbidities and real-time data provider for future medicine by increasing patient-provider engagement and compliance,” said Mehmet Kazgan, Founder & CEO of cliexa.

On March 5, 2019, the Agency for Healthcare Research and Quality (AHRQ) announced three winners from Phase 2 of the AHRQ Step Up App Challenge, a competition that was designed to address the need for patient-reported outcomes (PRO) data into clinical care. Out of 10 semifinalists, and over 50+ applicants, cliexa® was selected as the 3rd place winner, and will receive $25,000 in prize money.

cliexa is a HIPAA-compliant cross-communication platform that improves the quality of care, clinical workflow, income generation, and time spent with patients. Patients will play a more significant role in their care with cliexa and will be able to make valuable correlations to causative factors for pain flare-ups through remotely reported outcomes. The discrete clinical data and patient-reported outcomes enable providers to improve clinical decision making while reducing liability and billing concerns with payors. These algorithms help providers respond more efficiently to new data so their patients will have fewer complications or side effects. Payors will be provided with longitudinal data to understand the necessary treatment decisions and patient status better. This will lead to improved communication and greater efficiency in the billing process while expanding the understanding of clinical methods that support patient well-being for future coverage improvements.

cliexa-EASE is a native application developed for Phase II of the AHRQ Step Up App Challenge, designed to track physical function, pain interference and depression using PROMIS measures. The application also has a patient reporting function where the patient can see the recorded scores over time and email this to other care team members, as well as a medication and complication tracking functionality. The application was tested for functionality on 6 patients at an integrated pain center, New Health Services, in Denver, Colorado. The application helps clinics fully leveraging PRO data to integrate validated clinical assessments to patient intake and remote-monitoring processes while collecting clinical metrics and compliance data for quality reporting. The discrete clinical data and PRO data enable providers to improve clinical decision making while reducing liability and billing concerns.

cliexa-EASE White Paper (FB)

We want to thank the Agency for Healthcare Research and Quality for rewarding us this opportunity. It has been a pleasure working with the folks who have dedicated their time and resources to ensure a smooth operation. Congratulations to all other companies who participated in the Step Up App Challenge. We believe programs of this nature foster an environment for technological innovation and provide a great path for advancing the healthcare industry.

In 2018, cliexa was selected as one of Jumpstart Foundry’s portfolio companies. Jumpstart recognizes the value of recent healthcare industry trends including “Remote Patient Monitoring” and “Telehealth.” In their recent article, JSF featured cliexa in their discussion of these recent technological trends in healthcare.

One of the key challenges in healthcare that we are solving is being able to render results interpretable to patients and providers, while creating efficient, streamlined communication and workflow. cliexa’s Remote Monitoring platforms assist providers in making more informed decisions about treatment plans and enable them to respond more quickly to new data so their patients will have fewer complications or side effects. cliexa suite of products enables providers to deliver value-based care which translates to significant cost savings.

With clinically validated scoring models, our platform provides clinicians multiple reference points with correlations to identify the accuracy of patient reported data which will result in better patient and clinician experience and enables more responsive and preventive treatments.

Patients will play a greater role in their care with cliexa and will be able to make valuable correlations to causative factors for pain flare-ups through remotely reported outcomes. The discrete clinical data and patient-reported outcomes enable providers to improve clinical decision making, while reducing liability and billing concerns with payors. These algorithms help providers respond more efficiently to new data so their patients will have fewer complications or side effects.

Click here to learn more about cliexa’s Digital Solutions for Healthcare.